ClinicalTrials.govpublic full text
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
breast cancer female, hormone receptor positive malignant neoplasm of breast, palbociclib, breast cancer, pepi, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914828
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.